Michael A. Laflamme

Growth factor-based manufacturing of human pluripotent stem cell-derived cardiomyocytes using the vertical wheel bioreactor system

Abstract Background Multiple protocols have been reported for the large-scale generation of human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) in bioreactors using small molecules; however, no comparable bioreactor-based methods have been established using growth facto...